RONALD S LEVY Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for RONALD S LEVY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RONALD S LEVY. RONALD S LEVY is an Executive Vice President in UNIGENE LABORATORIES INC ($UGNE).
Address: 81 FULTON STREET BOONTON 07005 NJ
Companies in which RONALD S LEVY is an Insider
UNIGENE LABORATORIES INC
Industry: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
Position of RONALD S LEVY: Executive Vice President
Holdings: 1,838,575 shares
Latest Transaction: Mar 18 2010
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of RONALD S LEVY
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 18 2010 | UGNE | UNIGENE LABORATORI ... | LEVY RONALD S | Executive Vice Pres ... | Option Exercise | A | 1.20 | 100,000 | 120,000 | 470,000 | |
| Jan 20 2010 | UGNE | UNIGENE LABORATORI ... | LEVY RONALD S | Executive Vice Pres ... | Grant | A | 0.00 | 14,800 | 0 | 1,838,575 | 1.8 M to 1.8 M (+0.81 %) |
| Apr 08 2009 | UGNE | UNIGENE LABORATORI ... | LEVY RONALD S | Executive Vice Pres ... | Option Exercise | A | 0.60 | 30,000 | 18,000 | 370,000 | |
| Apr 08 2009 | UGNE | UNIGENE LABORATORI ... | LEVY RONALD S | Executive Vice Pres ... | Option Exercise | A | 0.60 | 30,000 | 18,000 | 340,000 | |
| Apr 08 2009 | UGNE | UNIGENE LABORATORI ... | LEVY RONALD S | Executive Vice Pres ... | Option Exercise | A | 0.60 | 30,000 | 18,000 | 310,000 | |
| Apr 08 2009 | UGNE | UNIGENE LABORATORI ... | LEVY RONALD S | Executive Vice Pres ... | Option Exercise | A | 0.60 | 30,000 | 18,000 | 280,000 | |
| Nov 14 2008 | UGNE | UNIGENE LABORATORI ... | LEVY RONALD S | Executive Vice Pres ... | Grant | A | 0.00 | 40,000 | 0 | 1,863,775 | 1.8 M to 1.9 M (+2.19 %) |